Clinical Trial Update: Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

The document reports the termination of a Phase 2 trial evaluating oxaliplatin with 5-fluorouracil in patients with recurrent or metastatic head and neck cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Nang Kuang Pharmaceutical Co., Ltd. | Conditions: Cancer of the Head and Neck, Neoplasms, Head and Neck | Phase 2 | Status: TERMINATED